Effect of anluohuaxian tablet combined with γ-IFN on schistosomal liver fibrosis

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 1, 2009, Pages 53-58

  Huang, Jiaquan ^a   Huang, Haiyan ^a,b   Jiao, Yuntao ^a   Ai, Guo ^a   Huang, Tiejun ^a   Li, Lan ^a   Yu, Haijing ^a   Ma, Ke ^a   Xiao, Fei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Xianning Firse People's Hospital   (China)

Author keywords

interferon; Anluohuaxian tablet; Hepatic pigmentation; Liver fibrosis; Schistosomiasis japonica; TGF 1 mRNA; TIMP 1

Indexed keywords

HERBACEOUS AGENT; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GENETICS; HUMAN; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMIASIS JAPONICA; TABLET;

ADOLESCENT; ADULT; ANIMALS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LIVER CIRRHOSIS; MALE; MICE; RANDOM ALLOCATION; RNA, MESSENGER; SCHISTOSOMIASIS JAPONICA; TABLETS; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 67650631592     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0111-7     Document Type: Article

References (15)

1. H.L. Weng W.M. Cai B.E. Wang 2003 Clinical study of anti-hepatic fibrosis effect of γ-IFN in patients with chronic hepatitis B Chin Med J (Chinese) 83 11 943 947
2. G.Z. Cheng D.W. Mao G.X. Li 2005 Effects of Anluohuaxian capsule on hepatic fibrosis indexes in patients with chronic hepatitis Chin J Integ Tradit Western Med Dig (Chinese) 13 2 1099
3. National Standard GB15977-1995 (China). Diagnostic criteria and principles of management of schistosomiasis[S]
4. Hepatic fibrosis Group under Chinese Liver Disease Association. 2002 Common understanding of diagnosis and effect of hepatic fibrosis Chin J Hepatol (Chinese) 10 5 327 328
5. W.L. Wu W.M. Cai M.G. Chen 2004 Blueprint for the diagnosis and assessment of therapeutic efficacy in liver fibrosis due to schistosomiasis Chin J Schistosomiasis Control (Chinese) 16 3 229 230
6. S.L. Friedman 2003 Liver fibrosis-from bench to bedside J Hepatol 38 Suppl1 38
7. W.L. Wu X.Z. Zhou Y.Y. Huang 2004 Long-term efficacy of pyquiton on Schistosomiasis japonica Chin J Infect Dis (Chinese) 22 4 238 241
8. R. Bataller D.A. Brenner 2005 Liver fibrosis J Clin Invest 1 2 209 218 (Pubitemid 40385459)
9. F.W. Shek R.C. Benyon 2004 How can transforming growth factor beta be targeted usefully to combat liver fibrosis? J Eur J Gastro Enterol Hepato 16 2 123 126 (Pubitemid 39049646)
10. T.H. Herbs T. Wege S. Milani 1997 Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis Am J Pathol 150 1647 1659 (Pubitemid 27193813)
11. F.R. Murphy R. Issa X. Zhou 2002 Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis J Biol Chem 277 11 069 11 076
12. Chen XB, Wu GL, Sun X, et al. Modern Parasitology (Chinese). Beijing: People's Military Medical Press, 2002.638
13. H. Ma Y.K. Zhu X.M. Ma 2005 Effects of γ-interferon on gene expression of collagen I, III and tissue inhibito of metalloproteinase 1 in dimethylnitrosamine-induced liver fibrosis in rats Chin Hepatol 10 92 94
14. J. Tao W.M. Cai B.B. Zhang 2006 Pigment deposit in liver of BALB/c mice infected by Schistosoma japonicum and its relation to the effect of praziquantel treatment Chin J Parasitol Parasitic Dis (Chinese) 24 1 79 80
15. M.H. Hurst A.L. Willingham 3rd R. Lindberg 2000 Tissue responses in experimental schistosomiasis japonica in the pig: a histopathologic study of different stages of single low- or high-dose infections Am J Trop Med Hyg 62 1 45 50